National MS society awards research grant to Anneli Peters and Lisa-Ann Gerdes
Klaus Faber Initiative for Progressive MS funded at the Institute of Clinical Neuroimmunology
January 2022: Our group leaders Anneli Peters and Lisa Ann Gerdes won a highly competitive research grant of 297.000 USD from the US-American National Multiple Sclerosis Society (NMSS).
November 2021: The Klaus Faber foundation has funded a new research initiative at the Institute of Clinical Neuroimmunology that aims to uncover disease driving mechanisms in multiple sclerosis.
Broader Epstein–Barr virus–specific T cell receptor repertoire in the MS TWIN STUDY
Longitudinal retinal changes in MOGAD
September 2022 - Epstein–Barr virus (EBV) infection precedes multiple sclerosis (MS) pathology and cross-reactive antibodies might link EBV infection to CNS autoimmunity. As an altered anti-EBV T cell reaction was suggested in MS, in collaboration with the Institute of Translational Neurology in Münster, the Gerdes Lab queried peripheral blood T cell ...
July 2022 - In contrast to multiple sclerosis, it was not sufficiently investigated whether patients with myelin-oligodendrocyte-glycoprotein-antibody (MOG-IgG)-associated disease (MOGAD) also show a relapse-independent, subclinical retinal neuro-axonal loss. Therefore, initiated by @NeuroVisionLab (Havla Lab), eighty patients ...